Capabilities

Acquisition of Oriel Therapeutics

Sandoz

Our attorneys represented Sandoz in its agreement to acquire Oriel Therapeutics, a privately held US pharmaceuticals company, gaining exclusive rights to a portfolio of generic drug candidates and related technologies targeting medicines in the inhalable respiratory drug market.

Email Disclaimer